| Product Code: ETC12836193 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Infectious Vaccines Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Infectious Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Infectious Vaccines Market - Industry Life Cycle |
3.4 Serbia Infectious Vaccines Market - Porter's Five Forces |
3.5 Serbia Infectious Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Infectious Vaccines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 Serbia Infectious Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Infectious Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives to improve immunization coverage in Serbia |
4.2.2 Growing awareness about the importance of vaccination and preventive healthcare |
4.2.3 Rising incidence of infectious diseases in Serbia |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and production |
4.3.2 Limited access to vaccines in certain regions of Serbia |
4.3.3 Concerns about vaccine safety and efficacy among some population groups |
5 Serbia Infectious Vaccines Market Trends |
6 Serbia Infectious Vaccines Market, By Types |
6.1 Serbia Infectious Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Infectious Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Serbia Infectious Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031F |
6.1.4 Serbia Infectious Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Serbia Infectious Vaccines Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2 Serbia Infectious Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Infectious Vaccines Market Revenues & Volume, By COVID-19, 2021 - 2031F |
6.2.3 Serbia Infectious Vaccines Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.4 Serbia Infectious Vaccines Market Revenues & Volume, By Hepatitis, 2021 - 2031F |
6.3 Serbia Infectious Vaccines Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Serbia Infectious Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Serbia Infectious Vaccines Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Serbia Infectious Vaccines Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4 Serbia Infectious Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Serbia Infectious Vaccines Market Revenues & Volume, By Public Health Agencies, 2021 - 2031F |
6.4.3 Serbia Infectious Vaccines Market Revenues & Volume, By Private Clinics, 2021 - 2031F |
7 Serbia Infectious Vaccines Market Import-Export Trade Statistics |
7.1 Serbia Infectious Vaccines Market Export to Major Countries |
7.2 Serbia Infectious Vaccines Market Imports from Major Countries |
8 Serbia Infectious Vaccines Market Key Performance Indicators |
8.1 Percentage increase in immunization coverage rates in Serbia |
8.2 Number of vaccination campaigns organized by the government or healthcare organizations |
8.3 Rate of adoption of new vaccines in the market |
9 Serbia Infectious Vaccines Market - Opportunity Assessment |
9.1 Serbia Infectious Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Infectious Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Infectious Vaccines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 Serbia Infectious Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Infectious Vaccines Market - Competitive Landscape |
10.1 Serbia Infectious Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Serbia Infectious Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here